The Senior Director of Medical Affairs Strategy at Disc Medicine is responsible for developing and executing the Medical Affairs strategy for the myeloproliferative neoplasm (MPN) portfolio, focusing initially on selcodebart for myelofibrosis-associated anemia. This role involves leading scientific engagement, KOL strategies, and evidence generation while collaborating with various cross-functional teams to align MPN medical priorities with the overall organizational strategy.
See how your résumé matches this role — and tailor it from what actually gets interviews.